Comparison of the incidence and pattern of interstitial lung disease during erlotinib and gefitinib treatment in Japanese Patients with non-small cell lung cancer: the Okayama Lung Cancer Study Group experience.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples